Tianjin Pharma DRT (SH600329)
Group Profile
Brand Story
Product Center
Group News
CN
CN
EN
search
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Story
Brand Story
Product Center
Product Family
Products and Services
Group News
Group News
Health Services
Brand Display
Health Information
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us
Tianjin Pharma DRT (SH600329)
35.17
+0.35 +1.01%
CN
EN
Home Page
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Story
Product Center
Product Family
Products and Services
Group News
Health Services
Brand Display
Health Information
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Online Mall
Investor Relations
Investor Contact
Home Page
Investor Relations
Investor Contact
Stock Information
Company Announcements
Investor Contact
Hotline:
022-27020892
Investor's Email:
drt600329@163.com
Investor Protection:
http://www.isc.com.cn/
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Home Page
>
Investor Relations
>
Investor Contact